admac corporate presentationunder the vision of mr. ajay batra, admac has grown from a sapling to a...

CORPORATE PRESENTATION

ORIGINYear of Establishment : June 1985

Founder : Ajay Batra (Entrepreneur Businessmen)

With faith that tomorrow will be better than today, knowledge and understanding of acute care market, customer partnerships and with HOPE as an ingredient, a revolution called ADMAC was born. In last 32 years under The Vision of Mr. Ajay Batra, ADMAC has grown from a sapling to a blossoming tree, ADMAC stands for epitome of medical excellence. Today ADMAC has three proud pillars;

1. ADMAC Life Sciences : A dedicated Oncology Manufacturing and Integrated Product Development Organization.

2. ADMAC Formulations : Manufacturing of Beta Lactum, Non Beta Lactum – Injectables, Tablets, Capsules, Ointments and Parenterals.

3. ADMAC Hospitality : A chain of Restaurants and Lounge's serving the un-met and under-met requirements of common people.


We are a Global Pharmaceutical Company providing affordable and innovative medicines for healthier lives

WE ARE

• A leading contract manufacturing company

• In-Licensing and Out- Licensing

• Product Development and Customization

• Fulfilling Un-met & Under- met needs• Building profitable and

sustainable proprietary products

• Strong pipeline of differentiated products

• Acess to affordable medicines

• Finished Dosages • Key Markets: Asia, MENA,

Africa, and CIS• Building sustainable business

Contract Manufacturing Proprietary Products Global Products


• Provide affordable and innovative medicines for healthier lives.

Customer Value Proposition• Bring expensive medicines within reach

• Help patients manage disease better

• Equip partners to succeed

• Ensure products are always on shelf

Strategic Choices• Offer our client with products which they value most and help our Partners to succeed through

our flexible supply chain services

Purpose


PRESENCE


Sudan

Uzbekistan

Vietnam

Russia

Kenya

Philippines

Peru

Myanmar

Srilanka

Yemen

Nepal

Madagascar

Fiji

Cambodia

Laso

CommercialPresencein

15Countries

• Excellent control over supply chain

• Encompass all critical capabilities – Process Development, Submission of Dossiers & Manufacturing Expertise

• Cost effective and high speed development

• Our expertise in packaging


STRENGTH

• Commited to progressive governance

• Adopted International governance & processes

• Highest standards of disclosures & transparency

• Code of Business Ethics


GOVERNACE

Oncology- Niche Therapeutic Area

GLOBAL GENERIC’s

• Leading Contract Manufacturing Company in India

• Global Commercialization presence in Sudan, Uzbekistan, Vietnam, Russia, Kenya,Philippines, Peru, Myanmar, Srilanka, Yemen, Nepal, Madagascar, Fiji, Cambodia & Laos

• Strong Oncology Manufacturing Infrastructure to address the needs of Oncology Market

• Robust Portfolio of Cytotoxic’s

• Track record of Business Development and Strategic Partnerships


Oncology- Niche Therapeutic Area

• Track Record: Consistent growth and sustainable delivery of profits

• Market Presence: Product in over 20 countries

• Significant Presence: India, Philippines, Uzbekistan, Russia

• Focus on new Products: 4-5 new products launches every year

• Geography Expansion: MENA, Africa and CIS


GLOBAL GENERIC’s

Finished Dosage Units

• State of the art manufacturing facility

• Approved by WHO GMP , Pharmacy and Poisons Board – Kenya, National Medicine & Poison Board– Sudan, FDA– Yemen, FDA– Uzbekistan, FDA, FDA– Philippines, DDA- Nepal, FDA- Srilanka, Food and Drug Board Authority– Myanmar

• Built up area of 50,000 sq. feet


BANDWIDTH


876543210V

alues

(in m

illio

ns

US

$)

Financial graph for 3 years

4.56

1.27

5.81

2.24

7.52

3.9

Total Total Total

2014-2015 2015-2016

Years

2016-2017

Export Export Export

SNAPSHOTS


TEAMplay smart are passionate about making a difference

are experienced willing to walk extra miles to succeed

play well together it’s cool to be a part of a winning team

care about their are on a exciting journey to create a nextlocal communities generation generic pharmaceutical company


A STRONG PLATFORMState of the art IPD facility

Creating a Profile of Global Generics Product Development

• Regulatory Team – Over 5

• IP Team – Over 5

• Integrate product development• Increase speed, flexibility, and reliability• Effective combination of chemistry and formulation skills with legal, regulatory and IP expertise


Our Aim, is to become one of the leading global generic

company providing tough to make and truly differentiated

products that meets patients unmet needs.

“Success is the sum of small efforts, repeated day in and day out”.

AIMING HIGH

admac corporate presentationunder the vision of mr. ajay batra, admac has grown from a sapling to a...

Documents